Novo CEO pressed by Senate to chop prices of obesity, diabetic issues medications CEO Lars Fruergaard Jørgensen instructed lawmakers the organization would take into consideration new talks with insurers with regards to the record price ranges of Wegovy and copyright whenever they pledge to help keep the medicines on their https://dave-s-hot-chicken-nutrit16150.timeblog.net/66471359/not-known-details-about-healthcare-news